Consolidated Statements of Operations - USD ($)	12 Months Ended
Sep. 30, 2021	Sep. 30, 2020
Income Statement [Abstract]
Revenues
Operating Expenses:
Research and development	12,240,503	8,812,810
General and administrative	9,836,412	8,094,614
Stock-based compensation – general and administrative	1,454,979	803,261
Total Operating Expenses	23,531,894	17,710,685
Operating Loss	(23,531,894)	(17,710,685)
Other Income (Expense):
Interest income	261,825	68,066
Gain on forgiveness of note payable - Paycheck Protection Program and accrued interest	166,557
Other income	59,917	110,207
Interest expense	(10,839)	(15,673)
Total Other Income, Net	477,460	162,600
Net Loss	(23,054,434)	(17,548,085)
Deemed dividend on warrant extension	1,450,876
Net Loss Applicable to Common Stockholders	$ (24,505,310)	$ (17,548,085)
Net Loss Per Share Applicable to Common Stockholders - Basic and Diluted (in Dollars per share)	$ (0.23)	$ (0.45)
Weighted Average Common Shares Outstanding (in Shares)
Basic and diluted (in Shares)	108,599,080	39,165,248

The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements. Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period. Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=125511455&loc=d3e1337-109256